NCT04362033

Brief Summary

The purpose of this study is to evaluate the stroke volume variation measured by both methods: transpulmonary thermodilution and electrical impedance tomography (EIT), during fluid responsiveness maneuvers and after fluid replacement in the immediate postoperative of coronary artery bypass grafting (CABG) patients. Patients will be hemodinamically monitored with the VolumeView set in combination with EV1000 clinical platform and the display of valuable volumetric parameters (Edwards Lifesciences, California, USA). Simultaneoulsy, patients will be monitored with Enlight Electrical Impedance Tomography (Timpel, São Paulo, Brazil). Hemodynamic data will be assessed at baseline 1, one minute after the passive leg raising maneuver, after PEEP increment, and after 500 mL of Lactated Ringer's (bolus infusion). Blood gases sample will be assessed before and immediatly after the protocol.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 22, 2018

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2020

Completed
Last Updated

April 24, 2020

Status Verified

January 1, 2020

Enrollment Period

1.7 years

First QC Date

January 31, 2020

Last Update Submit

April 23, 2020

Conditions

Keywords

cardiac surgeryfluid responsivenesstranspulmonary thermodilutionelectrical impedance tomographypassive leg raisingstroke volume variation

Outcome Measures

Primary Outcomes (2)

  • Difference between the variation of the stroke volume and impedance variation (mean difference in %)

    Mean difference between stroke volume variation and impedance variation during different fluid responsiveness maneuvers, baseline condition and after volume infusion assessed by transpulmonary thermodilution and pulse contour method for stroke volume using VolumeView system, and electrical impedance parameters measured by Electrical impedance tomography for impedance variation

    within 2 hours after patient admission in the ICU

  • Correlation between the variation of the stroke volume and impedance variation

    Correlation test between the change (delta) of stroke volume and impedance variation during different fluid responsiveness maneuvers, baseline condition and after volume infusion assessed by transpulmonary thermodilution and pulse contour method for stroke volume using VolumeView system, and electrical impedance parameters measured by Electrical impedance tomography for impedance variation

    within 2 hours after patient admission in the ICU

Secondary Outcomes (4)

  • Agreement between stroke volume variation (delta) (mean difference in %, CI and limits of agreement)

    within 2 hours after patient admission in the ICU

  • Agreement between stroke volume variation (SVV) delta during PLR maneuver and with the infusion of volume

    within 2 hours after patient admission in the ICU

  • To evaluate the ability of increment of PEEP to predict fluid responsiveness

    within 2 hours after patient admission in the ICU

  • Safety of assessment stroke volume by EIT during fluid responsiveness Test (delta of Sodium, in mEq/mL)

    within 2 hours after patient admission in the ICU

Study Arms (2)

PLR group

EXPERIMENTAL

Patients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization: In PLR arm, patients will be submitted to the PLR maneuver (patient is positioned from 45 grade of semi-recumbent position to dorsal decubitus and the legs are raised at 45 grade) firstly, then PEEP increment maneuver. At the end, all patients will receive a bolus of 500mL of Lactate Ringer's

Diagnostic Test: Passive Leg Raising (PLR) and PEEP increment (PEEP)

PEEP group

EXPERIMENTAL

Patients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization: In PEEP arm, patients will be submitted to the PEEP maneuver (consisted in increase the PEEP level 5 cmH2O above the mean airway pressure, patient is positioned in 45 grade of semi-recumbent position) firstly, then PLR maneuver. At the end, all patients will receive a bolus of 500mL of Lactate Ringer's

Diagnostic Test: Passive Leg Raising (PLR) and PEEP increment (PEEP)

Interventions

PLR: Fluid responsiveness maneuver which patient is positioned from 45 grade of semi-recumbent position to dorsal decubitus and the legs are raised at 45 grades; PEEP increment: Fluid responsiveness maneuver which consisted in increased the PEEP level 5 cmH2O above the mean airway pressure, patient is positioned in 45 grade of semi-recumbent position

PEEP groupPLR group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective CABG surgery
  • Age greater than 18 years old and less than 80 years old
  • Written inform consent

You may not qualify if:

  • Previous pulmonary disease or pulmonary hypertension
  • Previous renal replacement therapy
  • Left ventricular ejection fraction \< 40%
  • Body mass index \> 40 kg/m2
  • Atrial fibrillation
  • Presence of cardiac pacemaker or another implantable electronic device
  • Bleeding associated to hemodynamic instability
  • Cardiac arrest or suspicion of neurological alteration
  • Hemodynamic instability (norepinephrine dose \> 0.5 mcg/Kg/min)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Institute

São Paulo, São Paulo, 05403000, Brazil

RECRUITING

Related Publications (1)

  • Braun F, Proenca M, Wendler A, Sola J, Lemay M, Thiran JP, Weiler N, Frerichs I, Becher T. Noninvasive measurement of stroke volume changes in critically ill patients by means of electrical impedance tomography. J Clin Monit Comput. 2020 Oct;34(5):903-911. doi: 10.1007/s10877-019-00402-z. Epub 2019 Oct 17.

Central Study Contacts

Ludhmila A Hajjar, MD, PhD

CONTACT

Rafael M Ianotti, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Patients will be submitted to two different fluid responsiveness maneuvers in a cross over randomization.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor of Cardiology Department

Study Record Dates

First Submitted

January 31, 2020

First Posted

April 24, 2020

Study Start

August 22, 2018

Primary Completion

April 22, 2020

Study Completion

June 22, 2020

Last Updated

April 24, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations